methamphetamine hydrochloride
Generic: methamphetamine hydrochloride
Labeler: hikma pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
methamphetamine hydrochloride
Generic Name
methamphetamine hydrochloride
Labeler
hikma pharmaceuticals usa inc.
Dosage Form
TABLET
Routes
Active Ingredients
methamphetamine hydrochloride 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0054-0389
Product ID
0054-0389_9f3c9287-0615-4d2e-823d-673b33586e06
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203846
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2016-12-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00540389
Hyphenated Format
0054-0389
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
methamphetamine hydrochloride (source: ndc)
Generic Name
methamphetamine hydrochloride (source: ndc)
Application Number
ANDA203846 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (0054-0389-25)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9f3c9287-0615-4d2e-823d-673b33586e06", "openfda": {"upc": ["0300540389253"], "unii": ["997F43Z9CV"], "rxcui": ["977860"], "spl_set_id": ["90c02ac6-e5e2-4c97-8c68-81e4e389a195"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0054-0389-25)", "package_ndc": "0054-0389-25", "marketing_start_date": "20161206"}], "brand_name": "Methamphetamine Hydrochloride", "product_id": "0054-0389_9f3c9287-0615-4d2e-823d-673b33586e06", "dosage_form": "TABLET", "pharm_class": ["Amphetamine Anorectic [EPC]", "Amphetamines [CS]", "Appetite Suppression [PE]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]"], "product_ndc": "0054-0389", "dea_schedule": "CII", "generic_name": "Methamphetamine Hydrochloride", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Methamphetamine Hydrochloride", "active_ingredients": [{"name": "METHAMPHETAMINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA203846", "marketing_category": "ANDA", "marketing_start_date": "20161206", "listing_expiration_date": "20261231"}